Brian M. Culley, CEO and Director at ADVENTRX PHARMACEUTICALS INC (ANX), bought 14,000 shares at $0.58 ($8K) on 2012-03-13, disclosed to the SEC on 2012-03-14.
Open-market purchase of $8k ANX by CEO and Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LCTX | BUY | 2024-05-28 | $11K | — | Filing → |
| LCTX | BUY | 2022-04-04 | $10K | — | Filing → |
| LCTX | BUY | 2022-03-28 | $7K | — | Filing → |